tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IMTX Stock Latest News

Immatics price target raised to $19 from $16 at Mizuho
The FlyImmatics price target raised to $19 from $16 at Mizuho
9d ago
IMTX
Immatics Appoints Amie Krause as Chief People Officer Amidst Commercial Transition
PremiumCompany Announcements
Immatics Appoints Amie Krause as Chief People Officer Amidst Commercial Transition
11d ago
6K
IMTX
Immatics appoints Krause as Chief People Officer
PremiumThe Fly
Immatics appoints Krause as Chief People Officer
11d ago
IMTX
Immatics’ Promising Efficacy and Strategic Positioning Support Buy Rating
PremiumRatings
Immatics’ Promising Efficacy and Strategic Positioning Support Buy Rating
18d ago
IMTX
Immatics Reports Promising Anzu-cel Results in Uveal Melanoma
PremiumCompany Announcements
Immatics Reports Promising Anzu-cel Results in Uveal Melanoma
18d ago
6K
IMTX
Immatics highlights anti-tumor activity of anzu-cel PRAME cell therapy
PremiumThe FlyImmatics highlights anti-tumor activity of anzu-cel PRAME cell therapy
18d ago
IMTX
Immatics Appoints New CFO to Drive PRAME Therapy Commercialization
Premium
Company Announcements
Immatics Appoints New CFO to Drive PRAME Therapy Commercialization
1M ago
6K
IMTX
Immatics appoints Venkat Ramanan as Chief Financial Officer
Premium
The Fly
Immatics appoints Venkat Ramanan as Chief Financial Officer
1M ago
NVS
IMTX
Immatics initiated with a Buy at Guggenheim
PremiumThe Fly
Immatics initiated with a Buy at Guggenheim
2M ago
IMTX
Immatics initiated with a Buy at Guggenheim
PremiumThe Fly
Immatics initiated with a Buy at Guggenheim
2M ago
IMTX
Immatics N.V. Reports Q2 2025 Financial Results
PremiumCompany Announcements
Immatics N.V. Reports Q2 2025 Financial Results
3M ago
IMTX
Immatics Reports Q2 2025 Financial Results and Business Update
PremiumCompany Announcements
Immatics Reports Q2 2025 Financial Results and Business Update
3M ago
6K
IMTX
Immatics reports Q2 EPS (EUR 0.58) vs (EUR 0.17) last year
PremiumThe FlyImmatics reports Q2 EPS (EUR 0.58) vs (EUR 0.17) last year
3M ago
IMTX
IMTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
IMTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
IMTX
Immatics N.V. Shareholders Approve Key Resolutions at June 2025 AGM
Premium
Company Announcements
Immatics N.V. Shareholders Approve Key Resolutions at June 2025 AGM
5M ago
6K
IMTX
Immatics Announces Annual General Meeting for June 2025
PremiumCompany Announcements
Immatics Announces Annual General Meeting for June 2025
5M ago
6K
IMTX
Immatics Presents Promising IMA203 Data at ASCO 2025
PremiumCompany Announcements
Immatics Presents Promising IMA203 Data at ASCO 2025
5M ago
6K
IMTX
Immatics announces presentation of data from ongoing Phase 1b trial on IMA203
PremiumThe Fly
Immatics announces presentation of data from ongoing Phase 1b trial on IMA203
5M ago
IMTX
Immatics initiated with a Buy at Deutsche Bank
PremiumThe Fly
Immatics initiated with a Buy at Deutsche Bank
5M ago
IMTX
Immatics: Promising Pipeline and Financial Stability Drive Buy Rating
PremiumRatingsImmatics: Promising Pipeline and Financial Stability Drive Buy Rating
6M ago
IMTX
Immatics Reports Increased Q1 2025 Loss Amid Rising R&D Costs
Premium
Company Announcements
Immatics Reports Increased Q1 2025 Loss Amid Rising R&D Costs
6M ago
6K
IMTX
Immatics reports Q1 EPS (EUR 0.33) vs (EUR 0.03) last year
Premium
The Fly
Immatics reports Q1 EPS (EUR 0.33) vs (EUR 0.03) last year
6M ago
IMTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >